announces

Apparel Group India Announces Strategic Partnership to Launch Levi’s Kids in India

Iconic global denim brand expands into the fast-growing premium kidswear market through Apparel Group India's robust retail ecosystemMUMBAI, India, Dec.…

3 months ago

Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility

December 10, 2025 04:00 ET  | Source: Igyxos TOURS, France, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology…

3 months ago

IOC announces integrity measures ahead of Milano Cortina 2026

09 December 2025 – On International Anti-Corruption Day, celebrated worldwide on 9 December, the International Olympic Committee (IOC) announced the…

3 months ago

ADI Foundation Announces Launch of ADI Chain’s Mainnet and ADI Utility Token

ADI Foundation launches ADI Chain mainnet and native ADI utility token, unlocking a purpose-built Layer-2 blockchain for governments, regulated institutions,…

3 months ago

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced…

3 months ago

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement –– Strong activity observed…

3 months ago

HTX Group’s Affiliate HBGL Announces Soft Launch in Australia, Introducing Compliant Fiat-Stablecoin Services

PANAMA CITY, Panama, Dec. 8, 2025 /PRNewswire/ -- HBGL, a licensed digital asset service provider in Australia and an affiliate in…

3 months ago

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

3 months ago

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…

3 months ago

Strutt ev the CES 2026 Best of Innovation Winner Announces Super Early Bird Begins

The awards-winning robotics company officially kicks off its pre-order window ahead of its main launch at CES 2026.SINGAPORE, Dec. 6,…

3 months ago